Burning Rock Biotech Limi... (BNR)
NASDAQ: BNR
· Real-Time Price · USD
2.51
0.09 (3.72%)
At close: May 06, 2025, 3:59 PM
2.60
3.59%
After-hours: May 06, 2025, 04:16 PM EDT
3.72% (1D)
| Bid | 2.55 |
| Market Cap | 2.7M |
| Revenue (ttm) | 515.82M |
| Net Income (ttm) | -346.63M |
| EPS (ttm) | -4.63 |
| PE Ratio (ttm) | -0.54 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.8 |
| Volume | 150,620 |
| Avg. Volume (20D) | 15,376 |
| Open | 2.50 |
| Previous Close | 2.42 |
| Day's Range | 2.38 - 2.78 |
| 52-Week Range | 2.18 - 8.99 |
| Beta | 0.72 |
About BNR
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestina...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 12, 2020
Employees 786
Stock Exchange NASDAQ
Ticker Symbol BNR
Website https://www.brbiotech.com
1 month ago
-12.36%
Burning Rock Biotech shares are trading lower. The...
Unlock content with
Pro Subscription
5 months ago
+13.61%
Burning Rock Biotech shares are trading higher after the company reported a year-over-year increase in Q3 financial results.
